NVIDIA — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers.
BiotechHealthtechMedical DevicesNewtown Square, US
Zhengbin (Bing) Yao(Executive Officer, Director)inBrent Rice(Chief Commercial Officer)in
BoardJason Zhang(Director)Cong Xu(Director)Stuart Lutzker(Director)
Co-investorsCatalio Capital Management, LPForesite CapitalGeneral CatalystHBM Healthcare InvestmentsHBM PartnersHongShan Capital Group+4 more
Athelas develops software tools for private practice healthcare providers to reduce administrative burden, improve operational efficiency, and enhance patient scheduling and navigation capabilities.
AI & Machine LearningEnterprise SoftwareHealthtechSaaSSan Francisco, US
Deepika Bodapati(Founder)inTanay Tandon(Founder)inSteve Moffatt(Hardware and Operations)Wiley Jones(Hardware Engineer)Cynthia Jiang(Recruiter)John Zhao(Vice President \u0026 GM)
Co-investorsAmity VenturesDorm RoomFifty YearsGeneral CatalystHuman CapitalInitialized Capital+10 more
Databricks provides a unified platform for data engineering, analytics, and artificial intelligence, enabling organizations to build and deploy data and AI applications on cloud infrastructure.
AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSan Francisco, US
Ali Ghodsi(Founder)inIon Stoica(Founder)inMatei Zaharia(Founder)inReynold Xin(Founder)inPatrick Wendell(Founder)inAndy Konwinski(Founder)in
Co-investors137 VenturesA.Capital VenturesAglae VenturesAlkeon InnovationAlpha Square GroupAltra Venture+116 more
Inflection builds AI models that combine emotional and raw intelligence to create trustworthy AI agents for individuals and enterprises.
AI & Machine LearningEnterprise SoftwarePalo Alto, US
Reid Hoffman(Founder)inMustafa Suleyman(Founder)inKarén Simonyan(Founder)inSean White(Chief Executive Officer)inVibhu Mittal(Chief Technology Officer)inTed Shelton(Chief Operating Officer)in
Co-investorsChamaeleonCoreWeaveEric SchmidtGeneral PartnershipGreylock PartnersHorizons Ventures+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





.png)






















